186 results on '"Cambieri P"'
Search Results
2. MiR206 and 423-3p Are Differently Modulated in Fast and Slow-Progressing Amyotrophic Lateral Sclerosis Patients
- Author
-
Musarò, Antonio, Dobrowolny, Gabriella, Cambieri, Chiara, Libonati, Laura, Moret, Federica, Casola, Irene, Laurenzi, Gaia, Garibaldi, Matteo, Inghilleri, Maurizio, and Ceccanti, Marco
- Published
- 2024
- Full Text
- View/download PDF
3. Enterobacter asburiae ST229: an emerging carbapenemases producer
- Author
-
Mattioni Marchetti, Vittoria, Kuka, Angela, Piazza, Aurora, Gaiarsa, Stefano, Merla, Cristina, Sottosanti, Mariangela, Cambieri, Patrizia, Migliavacca, Roberta, and Baldanti, Fausto
- Published
- 2024
- Full Text
- View/download PDF
4. Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication
- Author
-
Libonati, Laura, Cambieri, Chiara, Colavito, Davide, Moret, Federica, D’Andrea, Edoardo, Del Giudice, Elda, Leon, Alberta, Inghilleri, Maurizio, and Ceccanti, Marco
- Published
- 2024
- Full Text
- View/download PDF
5. Impact of real-time PCR on Whipple’s disease diagnosis: the experience of Fondazione IRCCS Policlinico San Matteo
- Author
-
I. Mileto, C. Merla, D. De Vitis, M. Ardizzone, M. Corbella, F. Biagi, and P. Cambieri
- Subjects
Microbiology ,QR1-502 - Abstract
Not available.
- Published
- 2024
- Full Text
- View/download PDF
6. Impact of Whole Genome Sequencing to investigate transmission of Serratia marcescens in Neonatal Intensive Care Unit
- Author
-
Cristina Merla, Marina Ramus, Angela Kuka, Irene Mileto, Stefano Gaiarsa, Amelia Di Comite, Marta Corbella, Antonio Piralla, Marina Liliana Lanave, Alba Muzzi, Stefano Ghirardello, Fausto Baldanti, and Patrizia Cambieri
- Subjects
Serratia marcescens ,Neonatal Intensive Care Unit ,Whole Genome Sequencing ,Infection control ,Outbreak ,Infectious and parasitic diseases ,RC109-216 ,Public aspects of medicine ,RA1-1270 - Abstract
Newborns admitted to neonatal intensive care units (NICU) are at increased risk of health care-associated infections. Serratia marcescens represent the third most common pathogen in NICU outbreaks. Here we present an outbreak investigation performed using Whole Genome Sequencing (WGS) analyses and the control measures implemented to limit the spread of S. marcescens in the NICU of an Italian hospital. In February 2023 S. marcescens was isolated from six newborns, when in 2022 this pathogen was isolated only from two samples in the same ward. Measures for infection prevention were adopted. Routinary surveillance screening, performed with rectal swabs collected at admission and weekly thereafter, was implemented to search for S. marcescens presence. Environmental samples were collected. All the isolates, obtained from the conjunctival swab of six newborns, from rectal swab of two newborns who did not develop infections, as well as from the aerators of two faucets, were sequenced. WGS analyses showed no correlation between the isolates from newborns and environmental isolates. The implementation of the measures for infection prevention and control had enabled us to successfully control the outbreak within a short period. WGS analyses proved to be crucial in outbreak investigation to limit the spreading of the pathogens.
- Published
- 2024
- Full Text
- View/download PDF
7. Enterobacter asburiae ST229: an emerging carbapenemases producer
- Author
-
Vittoria Mattioni Marchetti, Angela Kuka, Aurora Piazza, Stefano Gaiarsa, Cristina Merla, Mariangela Sottosanti, Patrizia Cambieri, Roberta Migliavacca, and Fausto Baldanti
- Subjects
Enterobacter asburiae ,Epidemiology ,Surveillance ,Carbapenemase-producing ,NDM-1 ,VIM-1 ,Medicine ,Science - Abstract
Abstract Enterobacter asburiae, member of the Enterobacter cloacae complex (ECC) group, shows an increasing clinical relevance being responsible for infections like pneumonia, urinary tract infections and septicemia. The aim of the present study was the investigation of the genomic features of two XDR E. asburiae ST229 clinical strains co-carrying blaNDM-1 and blaVIM-1 determinants, collected in October 2021 and in June 2022, respectively. Two E. asburiae strains were collected from rectal swabs of as many patients admitted to the cardiopulmonary intensive care unit of Fondazione I.R.C.C.S. “Policlinico San Matteo” in Pavia, Italy. Based on the antibiotic susceptibility profile results, both isolates showed an XDR phenotype, retaining susceptibility only to fluoroquinolones. Both isolates shared identical resistome, virulome, plasmid content, and belonged to ST229, a rarely reported sequence type. They co-harbored blaNDM-1 and blaVIM-1 genes, that resulted located on transferable plasmids by conjugation and transformation. Moreover, both strains differed in 24 SNPs and showed genetic relatedness with E. asburiae ST709 and ST27. We described the first case of ST229 E. asburiae co-harboring blaNDM-1 and blaVIM-1 in Italy. This study points out the emergence of carbapenemases in low-risk pathogens, representing a novel challenge for public health, that should include such types of strains in dedicated surveillance programs. Antimicrobial susceptibility testing was carried out using Thermo Scientific™ Sensititre™ Gram Negative MIC Plates DKMGN. Both strains underwent whole-genome sequencing (WGS) using Illumina Miseq platform. Resistome, plasmidome, virulome, MLST, plasmid MLST and a SNPs-based phylogenetic tree were in silico determined.
- Published
- 2024
- Full Text
- View/download PDF
8. Outbreak of Candida parapsilosis fungemia in an intensive care unit during a COVID surge: an epidemic within a pandemic
- Author
-
Amatu, Alessandro, Trani, Ruben M., Voltini, Marta, Tavazzi, Guido, Capra Marzani, Federico, Cavanna, Caterina, Cambieri, Patrizia, Corbella, Marta, Muzzi, Alba, Baldanti, Fausto, and Mojoli, Francesco
- Published
- 2023
- Full Text
- View/download PDF
9. Retrospective observational study on the use of acetyl-l-carnitine in ALS
- Author
-
Sassi, Serena, Bianchi, Elisa, Diamanti, Luca, Tornabene, Danilo, Sette, Elisabetta, Medici, Doriana, Matà, Sabrina, Leccese, Deborah, Sperti, Martina, Martinelli, Ilaria, Ghezzi, Andrea, Mandrioli, Jessica, Iuzzolino, Valentina Virginia, Dubbioso, Raffaele, Trojsi, Francesca, Passaniti, Carla, D’Alvano, Giulia, Filosto, Massimiliano, Padovani, Alessandro, Mazzini, Letizia, De Marchi, Fabiola, Zinno, Lucia, Nuredini, Andi, Bongioanni, Paolo, Dolciotti, Cristina, Canali, Elena, Toschi, Giulia, Petrucci, Antonio, Perna, Alessia, Riso, Vittorio, Inghilleri, Maurizio, Libonati, Laura, Cambieri, Chiara, and Pupillo, Elisabetta
- Published
- 2023
- Full Text
- View/download PDF
10. Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study
- Author
-
Marco Fiore, Chiara Cambieri, Laura Libonati, Federica Moret, Edoardo D’Andrea, Maria Grazia Di Certo, Claudio Passananti, Francesca Gabanella, Nicoletta Corbi, Matteo Garibaldi, Cristina Chimenti, Maria Alfarano, Giampiero Ferraguti, Silvia Francati, Maurizio Inghilleri, and Marco Ceccanti
- Subjects
amyloidosis ,transthyretin ,oxidative stress ,FORT ,FORD ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Transthyretin-mediated amyloidosis (ATTR) is a systemic disease with protein precipitation in many tissues, mainly the peripheral nerve and heart. Both genetic (ATTRv, “v” for variant) and wild-type (ATTRwt) forms are known. Beyond the steric encumbrance, precipitated transthyretin seems to have a toxic effect. In this study carried out in men, we recruited 15 ATTRv patients, 7 ATTRv asymptomatic carriers, 14 ATTRwt patients and 10 young and 13 old healthy controls to evaluate the oxidative stress using FORD (Free Oxygen Radicals Defense) and FORT (Free Oxygen Radicals Test) analyses. ATTRv patients showed reduced FORD compared to ATTRwt and ATTRv asymptomatic carriers. FORD independently predicted the disease stage, with the early stages characterized by the highest consumption. These findings suggest a role for oxidative stress in the early stages of ATTRv.
- Published
- 2024
- Full Text
- View/download PDF
11. One-year surveillance for hypervirulent Klebsiella pneumoniae detected carbapenem-resistant superbugs
- Author
-
C. Merla, A. Kuka, I. Mileto, G. Petazzoni, S. Gaiarsa, D. De Vitis, M. Ardizzone, M. Corbella, F. Baldanti, and P. Cambieri
- Subjects
hypervirulent Klebsiella pneumoniae ,NDM ,multidrug resistance ,KPC ,ST23 ,ST86 ,Microbiology ,QR1-502 - Abstract
ABSTRACTHypervirulent Klebsiella pneumoniae (hvKp) can cause infections in clinically healthy people, such as young and immunocompetent patients. Genes involved in the capsule synthesis or those encoding the siderophores have been adopted as predictors of hvKp. Certain sequence types, such as ST23 and ST86, have been associated with hvKp strains, too. The aim of this study was to investigate the presence of hvKp among 354 K. pneumoniae strains isolated from clinical samples of patients admitted to an Italian 900-bed hospital between 21 May 2021 and April 2022. All the isolates were screened by PCR for the amplification of virulence loci. Whole genome sequencing was performed in strains tested positive for at least one target gene. Thirteen out of 354 (3.7%) were hvKp. Five were wild type and belonged to the hypervirulent clones ST23, ST86, ST5, and ST375 and to the new clone ST6310. Six strains carried the blaKPC gene: three belonged to ST101, two to ST512, and one to ST395. Two isolates were ST147 and carried the blaNDM gene. Although hvKp isolation is not frequent, their presence should be systematically investigated to avoid the spreading of both virulent strains and strains with combined increase in virulence and resistance to antibiotics. PCR-based protocols are essential for surveillance of these strains, which do not always show a recognizable phenotype. Moreover, hvKp strains were isolated also from patients without history of recent foreign travels, indicating an increased spreading of these strains as well as an underestimated of their circulation so far.IMPORTANCEKlebsiella pneumoniae is a healthcare-associated pathogen frequently resistant to antibiotics. Hypervirulent strains of pneumoniae (hvKp) can spread from the primary site of infection to multiple sites causing life-threatening infections also in young otherwise healthy individuals. This study described the isolation of 13 isolates of K. pneumoniae with increased virulence in a large tertiary hospital over a 1-year period. Among them, eight strains were multidrug resistant and hypervirulent. Although these hypervirulent strains are still rare in Italy, their presence is particularly concerning since they can cause difficult-to-treat life-threatening infections. Moreover, not all the hypervirulent isolates were positive by the string test, so hvKp isolates were not always phenotypically detectable. Molecular biology techniques such as PCR amplification and next generation sequencing are therefore necessary for the detection of hvKp isolates, and surveillance programs exploiting molecular techniques are highly desirable.
- Published
- 2024
- Full Text
- View/download PDF
12. Reduction of BSI associated mortality after a sepsis project implementation in the ER of a tertiary referral hospital
- Author
-
Seminari, Elena, Colaneri, Marta, Corbella, Marta, De Silvestri, Annalisa, Muzzi, Alba, Perlini, Stefano, Martino, Ilaria Francesca, Marvulli, Lea Nadia, Arcuri, Alessia, Maffezzoni, Marcello, Minucci, Rita, Bono, Enrica, Cambieri, Patrizia, Marone, Piero, and Bruno, Raffaele
- Published
- 2023
- Full Text
- View/download PDF
13. Correction: Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
- Author
-
Margotta, Cassandra, Fabbrizio, Paola, Ceccanti, Marco, Cambieri, Chiara, Rufolo, Gabriele, D’Agostino, Jessica, Trolese, Maria Chiara, Cifelli, Pierangelo, Alfano, Veronica, Laurini, Christian, Scaricamazza, Silvia, Ferri, Alberto, Sorarù, Gianni, Palma, Eleonora, Inghilleri, Maurizio, Bendotti, Caterina, and Nardo, Giovanni
- Published
- 2023
- Full Text
- View/download PDF
14. Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
- Author
-
Margotta, Cassandra, Fabbrizio, Paola, Ceccanti, Marco, Cambieri, Chiara, Ruffolo, Gabriele, D’Agostino, Jessica, Trolese, Maria Chiara, Cifelli, Pierangelo, Alfano, Veronica, Laurini, Christian, Scaricamazza, Silvia, Ferri, Alberto, Sorarù, Gianni, Palma, Eleonora, Inghilleri, Maurizio, Bendotti, Caterina, and Nardo, Giovanni
- Published
- 2023
- Full Text
- View/download PDF
15. Invasive Streptococcal Infection in Children: An Italian Case Series
- Author
-
Francesca Rivano, Martina Votto, Silvia Caimmi, Patrizia Cambieri, Riccardo Castagnoli, Marta Corbella, Mara De Amici, Maria De Filippo, Enrico Landi, Pavia Pediatric Task Force, Antonio Piralla, Ivan Taietti, Fausto Baldanti, Amelia Licari, and Gian Luigi Marseglia
- Subjects
group A streptococcus ,pharyngitis ,invasive infection ,children ,scarlet fever ,Pediatrics ,RJ1-570 - Abstract
Since October 2022, alerts have spread from several countries about the increase in invasive group A streptococcal (iGAS) and scarlet fever cases affecting young children. We aim to analyze the epidemiology of GAS infections in the last 12 years in our hospital and identify the clinical features of invasive cases observed in 2023. We conducted a retrospective study enrolling children and adolescents hospitalized at our pediatric clinic from January to December 2023 for a definitive diagnosis of iGAS infection. Clinical, laboratory, and imaging data were collected and analyzed. Comparing 2016 and 2023, we observed a similar number of GAS infections (65 vs. 60 cases). Five children with iGAS infection were hospitalized between March and April 2023. The median age was five years. At admission, all patients showed tachycardia disproportionate to their body temperature. Vomiting was a recurrent symptom (80%). Laboratory tests mostly showed lymphopenia, hyponatremia, and high inflammatory markers. The number of pediatric iGAS cases significantly increased in 2023. Clinical (pre-school-aged children with high fever, unexplained tachycardia, and vomiting) and laboratory parameters (high procalcitonin levels, hyponatremia, and lymphopenia) could help identify and suspect a potential iGAS infection.
- Published
- 2024
- Full Text
- View/download PDF
16. Bloodstream Infection Caused by Erysipelothrix rhusiopathiae in an Immunocompetent Patient
- Author
-
Irene Mileto, Cristina Merla, Marta Corbella, Stefano Gaiarsa, Angela Kuka, Stefania Ghilotti, Pasquale De Cata, Fausto Baldanti, and Patrizia Cambieri
- Subjects
Erysipelothrix rhusiopathiae ,bacteraemia ,bloodstream infection ,Biology (General) ,QH301-705.5 - Abstract
Erysipelothrix rhusiopathiae is a facultative anaerobe Gram-positive bacillus, which is considered a zoonotic pathogen. E. rhusiopathiae causes erysipeloid, mainly in occupational groups such as veterinarians, slaughterhouse workers, farmers, and fishermen. Two cutaneous forms (localised and generalised) and a septicaemic form have been described. Here, we report the isolation of a strain of E. rhusiopathiae from a 56-year-old immunocompetent obese male admitted to Fondazione IRCCS Policlinico San Matteo Pavia (Italy). Blood cultures were collected and Gram-positive bacilli were observed. E. rhusiopathiae grew and was identified. Antimicrobial susceptibility tests were performed and interpreted with EUCAST breakpoints (PK-PD). The strain was susceptible to all the antibiotics tested, while it was intrinsically resistant to vancomycin. The clinical diagnosis of E. rhusiopathiae can be challenging, due to the broad spectrum of symptoms and potential side effects, including serious systemic infections such as heart diseases. In the case described, bacteraemia caused by E. rhusiopathiae was detected in a immunocompetent patient. Bacteraemia caused by E. rhusiopathiae is rare in immunocompetent people and blood cultures were proven to be essential for the diagnosis and underdiagnosis of this pathogen, which is possible due to its resemblance to other clinical manifestations.
- Published
- 2024
- Full Text
- View/download PDF
17. Publisher Correction: Enterobacter asburiae ST229: an emerging carbapenemases producer
- Author
-
Vittoria Mattioni Marchetti, Angela Kuka, Aurora Piazza, Stefano Gaiarsa, Cristina Merla, Mariangela Sottosanti, Patrizia Cambieri, Roberta Migliavacca, and Fausto Baldanti
- Subjects
Medicine ,Science - Published
- 2024
- Full Text
- View/download PDF
18. Correction to: Retrospective observational study on the use of acetyl-l-carnitine in ALS
- Author
-
Sassi, Serena, Bianchi, Elisa, Diamanti, Luca, Tornabene, Danilo, Sette, Elisabetta, Medici, Doriana, Matà, Sabrina, Leccese, Deborah, Sperti, Martina, Martinelli, Ilaria, Ghezzi, Andrea, Mandrioli, Jessica, Iuzzolino, Valentina Virginia, Dubbioso, Raffaele, Trojsi, Francesca, Passaniti, Carla, D’Alvano, Giulia, Filosto, Massimiliano, Padovani, Alessandro, Mazzini, Letizia, De Marchi, Fabiola, Zinno, Lucia, Nuredini, Andi, Bongioanni, Paolo, Dolciotti, Cristina, Canali, Elena, Toschi, Giulia, Petrucci, Antonio, Perna, Alessia, Riso, Vittorio, Inghilleri, Maurizio, Libonati, Laura, Cambieri, Chiara, and Pupillo, Elisabetta
- Published
- 2023
- Full Text
- View/download PDF
19. Reduction of BSI associated mortality after a sepsis project implementation in the ER of a tertiary referral hospital
- Author
-
Elena Seminari, Marta Colaneri, Marta Corbella, Annalisa De Silvestri, Alba Muzzi, Stefano Perlini, Ilaria Francesca Martino, Lea Nadia Marvulli, Alessia Arcuri, Marcello Maffezzoni, Rita Minucci, Enrica Bono, Patrizia Cambieri, Piero Marone, and Raffaele Bruno
- Subjects
Medicine ,Science - Abstract
Abstract The emergency room (ER) is the first gateway for patients with sepsis to inpatient units, and identifying best practices and benchmarks to be applied in this setting might crucially result in better patient’s outcomes. In this study, we want to evaluate the results in terms of decreased the in-hospital mortality of patients with sepsis of a Sepsis Project developed in the ER. All patients admitted to the ER of our Hospital from the 1st January, 2016 to the 31stJuly 2019 with suspect of sepsis (MEWS score ≥ of 3) and positive blood culture upon ER admission were included in this retrospective observational study. The study comprises of two periods: Period A: From the 1st Jan 2016 to the 31st Dec 2017, before the implementation of the Sepsis project. Period B: From the 1st Jan 2018 to the 31stJul 2019, after the implementation of the Sepsis project. To analyze the difference in mortality between the two periods, a univariate and multivariate logistic regression was used. The risk of in-hospital mortality was expressed as an odds ratio (OR) and a 95% confidence interval (95% CI). Overall, 722 patients admitted in ER had positive BC on admissions, 408 in period A and 314 in period B. In-hospital mortality was 18.9% in period A and 12.7% in period B (p = 0.03). At multivariable analysis, mortality was still reduced in period B compared to period A (OR 0.64, 95% CI 0.41–0.98; p = 0.045). Having an infection due to GP bacteria or polymicrobial was associated with an increased risk of death, as it was having a neoplasm or diabetes. A marked reduction in in-hospital mortality of patients with documented BSI associated with signs or symptoms of sepsis after the implementation of a sepsis project based on the application of sepsis bundles in the ER.
- Published
- 2023
- Full Text
- View/download PDF
20. Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
- Author
-
Cassandra Margotta, Paola Fabbrizio, Marco Ceccanti, Chiara Cambieri, Gabriele Ruffolo, Jessica D’Agostino, Maria Chiara Trolese, Pierangelo Cifelli, Veronica Alfano, Christian Laurini, Silvia Scaricamazza, Alberto Ferri, Gianni Sorarù, Eleonora Palma, Maurizio Inghilleri, Caterina Bendotti, and Giovanni Nardo
- Subjects
Amyotrophic lateral sclerosis ,Mouse model ,ACh receptor ,Skeletal muscle ,Macrophages ,Myogenesis ,Pathology ,RB1-214 - Abstract
Abstract Background Amyotrophic lateral sclerosis (ALS) is a heterogeneous disease in terms of onset and progression rate. This may account for therapeutic clinical trial failure. Transgenic SOD1G93A mice on C57 or 129Sv background have a slow and fast disease progression rate, mimicking the variability observed in patients. Based on evidence inferring the active influence of skeletal muscle on ALS pathogenesis, we explored whether dysregulation in hindlimb skeletal muscle reflects the phenotypic difference between the two mouse models. Methods Ex vivo immunohistochemical, biochemical, and biomolecular methodologies, together with in vivo electrophysiology and in vitro approaches on primary cells, were used to afford a comparative and longitudinal analysis of gastrocnemius medialis between fast- and slow-progressing ALS mice. Results We reported that slow-progressing mice counteracted muscle denervation atrophy by increasing acetylcholine receptor clustering, enhancing evoked currents, and preserving compound muscle action potential. This matched with prompt and sustained myogenesis, likely triggered by an early inflammatory response switching the infiltrated macrophages towards a M2 pro-regenerative phenotype. Conversely, upon denervation, fast-progressing mice failed to promptly activate a compensatory muscle response, exhibiting a rapidly progressive deterioration of muscle force. Conclusions Our findings further pinpoint the pivotal role of skeletal muscle in ALS, providing new insights into underestimated disease mechanisms occurring at the periphery and providing useful (diagnostic, prognostic, and mechanistic) information to facilitate the translation of cost-effective therapeutic strategies from the laboratory to the clinic.
- Published
- 2023
- Full Text
- View/download PDF
21. Combining Genome Surveillance and Metadata To Characterize the Diversity of Staphylococcus aureus Circulating in an Italian Hospital over a 9-Year Period
- Author
-
U. Postiglione, G. Batisti Biffignandi, M. Corbella, C. Merla, E. Olivieri, G. Petazzoni, E. J. Feil, C. Bandi, P. Cambieri, S. Gaiarsa, M. Brilli, and D. Sassera
- Subjects
Staphylococcus aureus ,antibiotic resistance ,community acquired ,genomic surveillance ,hospital acquired ,risk factors ,Microbiology ,QR1-502 - Abstract
ABSTRACT Staphylococcus aureus is an opportunistic pathogen and a leading cause of morbidity and mortality worldwide. Genomic-based surveillance has greatly improved our ability to track the emergence and spread of high-risk clones, but the full potential of genomic data is only reached when used in conjunction with detailed metadata. Here, we demonstrate the utility of an integrated approach by leveraging a curated collection of clinical and epidemiological metadata of S. aureus in the San Matteo Hospital (Italy) through a semisupervised clustering strategy. We sequenced 226 sepsis S. aureus samples, recovered over a period of 9 years. By using existing antibiotic profiling data, we selected strains that capture the full diversity of the population. Genome analysis revealed 49 sequence types, 16 of which are novel. Comparative genomic analyses of hospital- and community-acquired infection ruled out the existence of genomic features differentiating them, while evolutionary analyses of genes and traits of interest highlighted different dynamics of acquisition and loss between antibiotic resistance and virulence genes. Finally, highly resistant clones belonging to clonal complexes (CC) 8 and 22 were found to be responsible for abundant infections and deaths, while the highly virulent CC30 was responsible for rare but deadly episodes of infections. IMPORTANCE Genome sequencing is an important tool in clinical microbiology, as it allows in-depth characterization of isolates of interest and can propel genome-based surveillance studies. Such studies can benefit from ad hoc methods of sample selection to capture the genomic diversity present in a data set. Here, we present an approach based on clustering of antibiotic resistance profiles that allows optimal sample selection for bacterial genomic surveillance. We apply the method to a 9-year collection of Staphylococcus aureus from a large hospital in northern Italy. Our method allows us to sequence the genomes of a large variety of strains of this important pathogen, which we then leverage to characterize the epidemiology in the hospital and to perform evolutionary analyses on genes and traits of interest. These analyses highlight different dynamics of acquisition and loss between antibiotic resistance and virulence genes.
- Published
- 2023
- Full Text
- View/download PDF
22. Phenotypic and Genotypic Assays to Evaluate Coagulase-Negative Staphylococci Biofilm Production in Bloodstream Infections
- Author
-
Giulia Grassia, Jessica Bagnarino, Mariangela Siciliano, Daniela Barbarini, Marta Corbella, Patrizia Cambieri, Fausto Baldanti, and Vincenzina Monzillo
- Subjects
biofilm ,bloodstream infection ,catheter ,coagulase-negative staphylococci (CoNS) ,S. epidermidis ,Biology (General) ,QH301-705.5 - Abstract
Coagulase-negative staphylococci (CoNS) are commensal on human body surfaces and, for years, they were not considered a cause of bloodstream infection and were often regarded as contamination. However, the involvement of CoNS in nosocomial infection is increasingly being recognized. The insertion of cannulas and intravascular catheters represents the primary source of CoNS entry into the bloodstream, causing bacteremia and sepsis. They owe their pathogenic role to their ability to produce biofilms on surfaces, such as medical devices. In this study, we evaluate the adhesive capacity of CoNS isolated from blood cultures by comparing a spectrophotometric phenotypic assay with genotypic analysis based on the evidence of the ica operon. We retrospectively reviewed the database of CoNS isolated from blood cultures from January to December 2021 that were considered responsible for 361 bloodstream infections. Eighty-nine CoNS were selected among these. Our data show that Staphylococcus epidermidis was the predominant species isolated, expressing greater adhesive capacities, especially those with the complete operon. Knowledge of the adhesive capabilities of a microorganism responsible for sepsis can be useful in implementing appropriate corrective and preventive measures, since conventional antibiotic therapy cannot effectively eradicate biofilms.
- Published
- 2024
- Full Text
- View/download PDF
23. Livestock-associated methicillin-resistant Staphylococcus aureus in inpatients: a snapshot from an Italian hospital
- Author
-
C. Merla, A. Kuka, G. Petazzoni, U. Postiglione, M. Zatelli, S. Gaiarsa, B. Mariani, M. Corbella, P. Marone, D. Sassera, and P. Cambieri
- Subjects
Livestock-associated MRSA ,ST398 ,mecA ,Microbiology ,QR1-502 - Abstract
Objectives: This study aimed to characterize livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) strains isolated from patients admitted to Policlinico San Matteo in Pavia, located in an Italian region with high livestock density. Methods: The starting dataset was composed by 353 MRSA strains isolated from blood cultures between 2011 and 2019 and in 954 MRSA isolated from nasal swabs, wound swabs, skin swabs, ulcer swabs, conjunctival swabs, urine and respiratory samples collected between 2018 and 2019. LA-MRSA was identified based on being MRSA resistant to tetracycline and negative for the PCR amplification of scn locus. Whole genome sequencing of the selected strains was performed, and virulence and resistance genes searched. Results: Five out of 353 MRSA isolates from blood cultures (1.4%) and nine out of 904 MRSA isolates obtained from other materials (1%) were resistant to tetracycline and negative for the scn locus. The 14 strains were also negative for the lukS-pv, tsst, eta and etb loci. Nine of the 14 strains belonged to ST398, the most common ST of LA-MRSA in Europe. ST398 isolates belonged to four spa-types, of which the prevalent was t899. Eight genomes had the cassette SCCmec type V, five genomes had SCCmec type IV and one genome lacked SCCmec, mecA and mecC. Conclusion: The frequency of LA-MRSA in the patients of this study (1.4% in blood cultures, 1% in other samples) is low but relatively constant over time prevalence and comparable to that found in the few studies performed on patients to date.
- Published
- 2022
- Full Text
- View/download PDF
24. The Unnamed Plateau (Western Desert of Egypt). New geological and geoarchaeological data from an exploration in a remote area
- Author
-
Maria Emilia Peroschi and Flavio Cambieri
- Subjects
anatexite formation ,eastern Sahara explorations ,geology of Egypt ,Gilf B cultural phase ,Botany ,QK1-989 ,Geology ,QE1-996.5 - Abstract
The Unnamed Plateau is a low plateau in the Western Desert of Egypt close to the Libyan border, about halfway between the Gilf Kebir to the north and Jebel Uweinat to the south. It is little known and seldom visited. In the past, we have conducted three field surveys in order to assess its geomorphic features and the human presence in the Holocene. During our explorations we have found a Paleozoic fossil plant, which allows to ascribe the sedimentary cover to the late Paleozoic (as in the Geologic Map of Egypt, 1981), not Mesozoic, as indicated in the 1987 Geologic Map. We could retrace and walk an ancient mountain path connecting the two slopes of the Plateau and leading to a fossil lake. The area was visited by hunters-gatherers and perhaps the first nomadic herders moving north-south, until the mid-IV Millennium BC, when the final desiccation of the Eastern Sahara pushed them out definitely.
- Published
- 2023
- Full Text
- View/download PDF
25. Klebsiella pneumoniae ipervirulenta: una nuova emergenza? L’esperienza della Fondazione IRCCS Policlinico San Matteo di Pavia
- Author
-
I. Mileto, A. Kuka, C. Merla, M. Corbella, F. Baldanti, and P. Cambieri
- Subjects
Microbiology ,QR1-502 - Abstract
Not available.
- Published
- 2023
- Full Text
- View/download PDF
26. A novel homozygous mutation in TBK1 gene causing ALS-FTD
- Author
-
Libonati, Laura, Ceccanti, Marco, Cambieri, Chiara, Colavito, Davide, Moret, Federica, Fiorini, Ilenia, and Inghilleri, Maurizio
- Published
- 2022
- Full Text
- View/download PDF
27. Correction: Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
- Author
-
Cassandra Margotta, Paola Fabbrizio, Marco Ceccanti, Chiara Cambieri, Gabriele Rufolo, Jessica D’Agostino, Maria Chiara Trolese, Pierangelo Cifelli, Veronica Alfano, Christian Laurini, Silvia Scaricamazza, Alberto Ferri, Gianni Sorarù, Eleonora Palma, Maurizio Inghilleri, Caterina Bendotti, and Giovanni Nardo
- Subjects
Pathology ,RB1-214 - Published
- 2023
- Full Text
- View/download PDF
28. A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19
- Author
-
Rita Murri, Jacopo Lenkowicz, Carlotta Masciocchi, Chiara Iacomini, Massimo Fantoni, Andrea Damiani, Antonio Marchetti, Paolo Domenico Angelo Sergi, Giovanni Arcuri, Alfredo Cesario, Stefano Patarnello, Massimo Antonelli, Rocco Bellantone, Roberto Bernabei, Stefania Boccia, Paolo Calabresi, Andrea Cambieri, Roberto Cauda, Cesare Colosimo, Filippo Crea, Ruggero De Maria, Valerio De Stefano, Francesco Franceschi, Antonio Gasbarrini, Ornella Parolini, Luca Richeldi, Maurizio Sanguinetti, Andrea Urbani, Maurizio Zega, Giovanni Scambia, Vincenzo Valentini, and The Gemelli against Covid Group
- Subjects
Medicine ,Science - Abstract
Abstract The COVID-19 pandemic is impressively challenging the healthcare system. Several prognostic models have been validated but few of them are implemented in daily practice. The objective of the study was to validate a machine-learning risk prediction model using easy-to-obtain parameters to help to identify patients with COVID-19 who are at higher risk of death. The training cohort included all patients admitted to Fondazione Policlinico Gemelli with COVID-19 from March 5, 2020, to November 5, 2020. Afterward, the model was tested on all patients admitted to the same hospital with COVID-19 from November 6, 2020, to February 5, 2021. The primary outcome was in-hospital case-fatality risk. The out-of-sample performance of the model was estimated from the training set in terms of Area under the Receiving Operator Curve (AUROC) and classification matrix statistics by averaging the results of fivefold cross validation repeated 3-times and comparing the results with those obtained on the test set. An explanation analysis of the model, based on the SHapley Additive exPlanations (SHAP), is also presented. To assess the subsequent time evolution, the change in paO2/FiO2 (P/F) at 48 h after the baseline measurement was plotted against its baseline value. Among the 921 patients included in the training cohort, 120 died (13%). Variables selected for the model were age, platelet count, SpO2, blood urea nitrogen (BUN), hemoglobin, C-reactive protein, neutrophil count, and sodium. The results of the fivefold cross-validation repeated 3-times gave AUROC of 0.87, and statistics of the classification matrix to the Youden index as follows: sensitivity 0.840, specificity 0.774, negative predictive value 0.971. Then, the model was tested on a new population (n = 1463) in which the case-fatality rate was 22.6%. The test model showed AUROC 0.818, sensitivity 0.813, specificity 0.650, negative predictive value 0.922. Considering the first quartile of the predicted risk score (low-risk score group), the case-fatality rate was 1.6%, 17.8% in the second and third quartile (high-risk score group) and 53.5% in the fourth quartile (very high-risk score group). The three risk score groups showed good discrimination for the P/F value at admission, and a positive correlation was found for the low-risk class to P/F at 48 h after admission (adjusted R-squared = 0.48). We developed a predictive model of death for people with SARS-CoV-2 infection by including only easy-to-obtain variables (abnormal blood count, BUN, C-reactive protein, sodium and lower SpO2). It demonstrated good accuracy and high power of discrimination. The simplicity of the model makes the risk prediction applicable for patients in the Emergency Department, or during hospitalization. Although it is reasonable to assume that the model is also applicable in not-hospitalized persons, only appropriate studies can assess the accuracy of the model also for persons at home.
- Published
- 2021
- Full Text
- View/download PDF
29. Epidemiology and microbiology of prosthetic joint infections: a nine-year, single-center experience in Pavia, Northern Italy
- Author
-
Mussa, M., Manciulli, T., Corbella, M., Mariani, B., Cambieri, P., Gipsz, N., Scudeller, L., Abbott, D. M., Brunetti, E., Mosconi, M., Benazzo, F., and Orsolini, P.
- Published
- 2021
- Full Text
- View/download PDF
30. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
- Author
-
Bruno, R, Mondelli, M, Brunetti, E, Di Matteo, A, Seminari, E, Maiocchi, L, Zuccaro, V, Pagnucco, L, Mariani, B, Ludovisi, S, Lissandrin, R, Parisi, A, Sacchi, P, Patruno, SFA, Michelone, G, Gulminetti, R, Zanaboni, D, Novati, S, Maserati, R, Orsolini, P, Vecchia, M, Sciarra, M, Asperges, E, Colaneri, M, Di Filippo, A, Sambo, M, Biscarini, S, Lupi, M, Roda, S, Pieri, TC, Gallazzi, I, Sachs, M, Valsecchi, P, Perlini, S, Alfano, C, Bonzano, M, Briganti, F, Crescenzi, G, Falchi, AG, Guarnone, R, Guglielmana, B, Maggi, E, Martino, I, Pettenazza, P, Pioli di Marco, S, Quaglia, F, Sabena, A, Salinaro, F, Speciale, F, Zunino, I, De Lorenzo, M, Secco, G, Dimitry, L, Cappa, G, Maisak, I, Chiodi, B, Sciarrini, M, Barcella, B, Resta, F, Moroni, L, Vezzoni, G, Scattaglia, L, Boscolo, E, Zattera, C, Tassi, MF, Capozza, V, Vignaroli, D, Bazzini, M, Iotti, G, Mojoli, F, Belliato, M, Perotti, L, Mongodi, S, Tavazzi, G, Marseglia, G, Licari, A, Brambilla, I, Barbarini, D, Bruno, A, Cambieri, P, Campanini, G, Cavanna, C., Comolli, G, Corbella, M, Daturi, R, Furione, M, Marone, P, Monzillo, E, Paolucci, S, Parea, M, Percivalle, E, Piralla, A, Rovida, F, Sarasini, A, Zavattoni, M, Adzasehoun, G, Ardizzone, M, Bellotti, L, Brunco, V, Cabano, E, Casali, G, Capella, L, Devitis, D, Dossena, L, Frisco, G, Garbagnoli, G, Gardellini, F, Girello, A, Guerrizio, A, Landini, V, Lucchelli, C, Maliardi, V, Piemontese, P, Pezzaia, S, Premoli, M, Rebuffa, C, Zanello, C, Bagnarino, J, Bergami, F, Bonetti, A, Caneva, G, Cassaniti, I, Corcione, A, Di Martino, R, Di Napoli, A, Ferrari, A, Ferrari, G, Fiorina, L, Gallone, A, Giardina, F, Girardi, A, Mercato, A, Merla, C, Novazzi, F, Ratano, G, Rossi, B, Saveriaempillai, G, Sciabica, IM, Tallarita, M, Vecchio Nepita, E, Vitali, J, Cerino, A, Varchetta, S, Oliviero, B, Mantovani, S, Mele, D, Calvi, M, Tizzoni, M, Nicora, C, Triarico, A, Petronella, V, Marena, C, Muzzi, A, Lago, P, Cutti, S, Novelli, V, Comandatore, F, BatistiBiffignandi, G, Gaiarsa, S, Rettani, M, Bandi, C, Paolucci, Stefania, Cassaniti, Irene, Novazzi, Federica, Fiorina, Loretta, Piralla, Antonio, Comolli, Giuditta, Bruno, Raffaele, Maserati, Renato, Gulminetti, Roberto, Novati, Stefano, Mojoli, Francesco, and Baldanti, Fausto
- Published
- 2021
- Full Text
- View/download PDF
31. Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
- Author
-
Marco Ceccanti, Laura Libonati, Gabriele Ruffolo, Pierangelo Cifelli, Federica Moret, Vittorio Frasca, Eleonora Palma, Maurizio Inghilleri, and Chiara Cambieri
- Subjects
myasthenia gravis ,acetylcholine receptors ,repetitive nerve stimulation ,quantitative myasthenia gravis test ,anti-AChR antibodies ,3,4-diaminopyridine (3,4-DAP) ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Background: 3,4-diaminopyridine (3,4-DAP) can lead to clinical and electrophysiological improvement in myasthenic syndrome; it may thus represent a valuable therapeutic option for patients intolerant to pyridostigmine.Objective: to assess 3,4-diaminopyridine (3,4-DAP) effects and tolerability in patients with anti-AChR myasthenia gravis.Method: Effects were monitored electrophysiologically by repetitive nerve stimulation (RNS) and by standardized clinical testing (QMG score) before and after a single dose administration of 3,4-DAP 10 mg per os in 15 patients. Patients were divided according to their Myasthenia Gravis Foundation of America (MGFA) class into mild and severe.Results: No significant side effects were found, apart from transient paresthesia. 3,4-DAP had a significant effect on the QMG score (p = 0.0251), on repetitive nerve stimulation (p = 0.0251), and on the forced vital capacity (p = 0.03), thus indicating that it may reduce the level of disability and the decremental muscle response. When the patients were divided according to the MGFA classification, 3,4-DAP showed a positive effect in the severe group, either for the QMG score (p = 0.031) or for the RNS decrement (p = 0.031). No significant difference was observed in any of the outcome measures within the mild group (p > 0.05). A direct effect of 3,4-DAP on nicotinic ACh receptors (nAChRs) was excluded since human nAChRs reconstituted in an expression system, which were not affected by 3,4-DAP application.Conclusion: Our results suggest that 3,4-DAP may be a useful add-on therapy, especially in most severe patients or when immunosuppressive treatment has not yet reached its full effect or when significant side-effects are associated with anticholinesterase.
- Published
- 2022
- Full Text
- View/download PDF
32. Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study
- Author
-
Valentina Zuccaro, Greta Petazzoni, Irene Mileto, Marta Corbella, Erika Asperges, Paolo Sacchi, Sara Rattotti, Marzia Varettoni, Irene Defrancesco, Patrizia Cambieri, Fausto Baldanti, Luca Arcaini, and Raffaele Bruno
- Subjects
gut microbiota ,B cell receptor inhibitors ,chronic lymphocytic leukemia ,clinical response ,Biology (General) ,QH301-705.5 - Abstract
Several studies have strengthened the link between the gut microbiota (GM) and the response to immunotherapy in patients with tumors, highlighting the potential role of GM as a biomarker of response. Targeted therapies including B-cell receptor (BCR) inhibitors (BCRi) represent the newest approach to the treatment of chronic lymphocytic leukemia (CLL); however, not all patients achieve a satisfactory response, and immune-related adverse events (irAEs) can also impact the efficacy. The aim of the study was to compare GM biodiversity in patients with CLL, treated with BCRi for at least 12 months. Twelve patients were enrolled: 10 patients in the responder group (R) and 2 patients in the non-responder group (NR). We identified seven patients (58.3%) who experienced adverse reactions (AE). Although we did not observe a significant difference across the study population in terms of relative abundance and alpha and beta diversity, we found a differing distribution of bacterial taxa between the analyzed groups. We noted a higher level of the class Bacteroidia and the order Bacteroidales in the R group, and an inversion in the Firmicutes and Bacteroidetes ratio in the AE group. No prior studies have focused on linking GM and response to BCRi in these patients. Although the analyses are preliminary, they provide suggestions to guide future research.
- Published
- 2023
- Full Text
- View/download PDF
33. Extensively drug-resistant Proteus mirabilis strain harbouring blaNDM-1, blaVEB-6 and blaTEM-92 genes isolated from urine in Italy
- Author
-
Cristina Merla, Gherard Batisti Biffignandi, Marta Corbella, Carolina Ferrari, Annapia Di Napoli, Erika Scaltriti, Bianca Mariani, Piero Marone, Davide Sassera, and Patrizia Cambieri
- Subjects
Microbiology ,QR1-502 - Published
- 2021
- Full Text
- View/download PDF
34. A case of acute motor and sensory axonal neuropathy mimicking brain death
- Author
-
Libonati, Laura, Fiorini, Ilenia, Cambieri, Chiara, Ceccanti, Marco, and Inghilleri, Maurizio
- Published
- 2021
- Full Text
- View/download PDF
35. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
- Author
-
Stefania Paolucci, Irene Cassaniti, Federica Novazzi, Loretta Fiorina, Antonio Piralla, Giuditta Comolli, Raffaele Bruno, Renato Maserati, Roberto Gulminetti, Stefano Novati, Francesco Mojoli, Fausto Baldanti, R Bruno, M Mondelli, E Brunetti, A Di Matteo, E Seminari, L Maiocchi, V Zuccaro, L Pagnucco, B Mariani, S Ludovisi, R Lissandrin, A Parisi, P Sacchi, SFA Patruno, G Michelone, R Gulminetti, D Zanaboni, S Novati, R Maserati, P Orsolini, M Vecchia, M Sciarra, E Asperges, M Colaneri, A Di Filippo, M Sambo, S Biscarini, M Lupi, S Roda, TC Pieri, I Gallazzi, M Sachs, P Valsecchi, S Perlini, C Alfano, M Bonzano, F Briganti, G Crescenzi, AG Falchi, R Guarnone, B Guglielmana, E Maggi, I Martino, P Pettenazza, S Pioli di Marco, F Quaglia, A Sabena, F Salinaro, F Speciale, I Zunino, M De Lorenzo, G Secco, L Dimitry, G Cappa, I Maisak, B Chiodi, M Sciarrini, B Barcella, F Resta, L Moroni, G Vezzoni, L Scattaglia, E Boscolo, C Zattera, MF Tassi, V Capozza, D Vignaroli, M Bazzini, G Iotti, F Mojoli, M Belliato, L Perotti, S Mongodi, G Tavazzi, G Marseglia, A Licari, I Brambilla, D Barbarini, A Bruno, P Cambieri, G Campanini, C. Cavanna, G Comolli, M Corbella, R Daturi, M Furione, P Marone, E Monzillo, S Paolucci, M Parea, E Percivalle, A Piralla, F Rovida, A Sarasini, M Zavattoni, G Adzasehoun, M Ardizzone, L Bellotti, V Brunco, E Cabano, G Casali, L Capella, D Devitis, L Dossena, G Frisco, G Garbagnoli, F Gardellini, A Girello, A Guerrizio, V Landini, C Lucchelli, V Maliardi, P Piemontese, S Pezzaia, M Premoli, C Rebuffa, C Zanello, J Bagnarino, F Bergami, A Bonetti, G Caneva, I Cassaniti, A Corcione, R Di Martino, A Di Napoli, A Ferrari, G Ferrari, L Fiorina, A Gallone, F Giardina, A Girardi, A Mercato, C Merla, F Novazzi, G Ratano, B Rossi, G Saveriaempillai, IM Sciabica, M Tallarita, E Vecchio Nepita, J Vitali, A Cerino, S Varchetta, B Oliviero, S Mantovani, D Mele, M Calvi, M Tizzoni, C Nicora, A Triarico, V Petronella, C Marena, A Muzzi, P Lago, S Cutti, V Novelli, F Comandatore, G BatistiBiffignandi, S Gaiarsa, M Rettani, and C Bandi
- Subjects
COVID-19 ,EBV DNA ,Lymphocyte subpopulation ,Infectious and parasitic diseases ,RC109-216 - Abstract
Objectives: The immunologic profile and opportunistic viral DNA increase were monitored in Italian patients with COVID-19 in order to identify markers of disease severity. Methods: A total of 104 patients infected with SARS-CoV-2 were evaluated in the study. Of them, 42/104 (40.4%) were hospitalized in an intensive care unit (ICU) and 62/104(59.6%) in a sub-intensive care unit (SICU). Human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV), Parvovirus B19 and Human Herpesvirus 6 virus reactivations were determined by real-time PCR, and lymphocyte subpopulation counts were determined by flow cytometry. Results: Among opportunistic viruses, only EBV was consistently detected. EBV DNA was observed in 40/42 (95.2%) of the ICU patients and in 51/61 (83.6%) of the SICU patients. Comparing the two groups of patients, the EBV DNA median level among ICU patients was significantly higher than that observed in SICU patients. In parallel, a significant reduction of CD8 T cell and NK count in ICU patients as compared with SICU patients was observed (p
- Published
- 2021
- Full Text
- View/download PDF
36. Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era
- Author
-
Eugenio Mercuri, Giuseppe Zampino, Alisha Morsella, Marika Pane, Roberta Onesimo, Carmen Angioletti, Piero Valentini, Claudia Rendeli, Antonio Ruggiero, Lorenzo Nanni, Antonio Chiaretti, Giovanni Vento, David Korn, Emilio Meneschincheri, Paolo Sergi, Giovanni Scambia, Walter Ricciardi, Andrea Cambieri, and Antonio Giulio De Belvis
- Subjects
Pediatrics ,RJ1-570 - Abstract
Abstract Background Suspending ordinary care activities during the COVID-19 pandemic made it necessary to find alternative routes to comply with care recommendations not only for acute health needs but also for patients requiring follow-up and multidisciplinary visits. We present the ‘Contactless’ model, a comprehensive operational tool including a plurality of services delivered remotely, structured according to a complexity gradient, aimed to cover diagnostic procedures and monitor disease progression in chronic pediatric patients. Methods A multidisciplinary and multiprofessional project team was recruited, in collaboration with patients’ associations, to map a panel of available Evidence-Based solutions and address individual needs in full respect of the concept of personalized medicine. The solutions include a number of services from videoconsultations to more structure videotraining sessions. Results A modular framework made up of four three Macro-levels of complexity - Contactless Basic, Intermediate and Advanced - was displayed as an incremental set of services and operational planning establishing each phase, from factors influencing eligibility to the delivery of the most accurate and complex levels of care. Conclusion The multimodal, multidisciplinary ‘Contactless’ model allowed the inclusion of all Units of our Pediatric Department and families with children with disability or complex chronic conditions. The strengths of this project rely on its replicability outside of pediatrics and in the limited resources needed to practically impact patients, caregivers and professionals involved in the process of care. Its implementation in the future may contribute to reduce the duration of hospital admissions, money and parental absence from work.
- Published
- 2021
- Full Text
- View/download PDF
37. Effects of Skin Stimulation on Sensory-Motor Networks Excitability: Possible Implications for Physical Training in Amyotrophic Lateral Sclerosis
- Author
-
Marco Ceccanti, Chiara Cambieri, Laura Libonati, Giorgio Tartaglia, Federica Moret, Matteo Garibaldi, and Maurizio Inghilleri
- Subjects
paired associative stimulation ,sensory-motor networks ,amyotrophic lateral sclerosis ,brain stimulation ,cortical excitability ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundMany different trials were assessed for rehabilitation of patients with amyotrophic lateral sclerosis (ALS), with non-unique results. Beside the effects on muscle trophism, some of the encouraging results of physical training could be ascribed to the modulation of cortical excitability, which was found hyperexcited in ALS.ObjectiveThe effects of tactile skin stimulation in the modulation of the sensory-motor integrative networks in healthy subjects were assayed through the paired associative stimulation (PAS) protocol.MethodsIn total, 15 healthy subjects were enrolled. In the standard PAS session, the average amplitude of the motor evoked potential (MEP) after 10 stimuli of transcranial magnetic stimulation (TMS) was measured at the baseline and after the PAS protocol (0, 10, 20, 30, and 60 min). In the skin stimulation session, the average amplitude of the MEP was measured before and after 10 min of skin stimulation over the hand. Subsequently, each subject underwent the PAS stimulation and the measure of the average amplitude of the MEP (0, 10, 20, 30, and 60 min).ResultsThe tactile skin stimulation on healthy subjects increases the PAS-induced sensory-motor network hyperexcitability in healthy subjects.ConclusionSkin stimulation should be avoided in the physiotherapeutic approaches for patients with ALS, given the possible hyperexciting effects on the already upmodulated sensory-motor networks. They can be taken into account for diseases characterized by downregulation of cortical and transcortical networks.
- Published
- 2022
- Full Text
- View/download PDF
38. One-year surveillance for hypervirulent Klebsiella pneumoniae detected carbapenem-resistant superbugs
- Author
-
Merla, C., primary, Kuka, A., additional, Mileto, I., additional, Petazzoni, G., additional, Gaiarsa, S., additional, De Vitis, D., additional, Ardizzone, M., additional, Corbella, M., additional, Baldanti, F., additional, and Cambieri, P., additional
- Published
- 2024
- Full Text
- View/download PDF
39. Surveillance in a Neonatal Intensive Care Unit Allowed the Isolation of a Strain of VIM-Producing Pantoea brenneri
- Author
-
Cristina Merla, Irene Mileto, Stefano Gaiarsa, Cristian Achille, Stefano Ghirardello, Marta Corbella, Fausto Baldanti, and Patrizia Cambieri
- Subjects
verona integron β-lactamase ,screening for carbapenemase-resistant Enterobacterales ,newborn ,neonatal intensive care unit ,Pantoea brenneri ,VIM ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Here, we describe the isolation of a strain of the genus Pantoea encoding a VIM carbapenemase, the first to our knowledge. The strain, isolated from a rectal swab of a 10-day-old newborn admitted to a neonatal intensive care unit (NICU), was identified through whole-genome sequencing analyses as Pantoea brenneri. The strain harbored the carbapenemases gene blaVIM-1. The prompt application of contact measures and the isolation of the newborn prevented the dissemination of VIM-producing P. brenneri and of the plasmid carrying the VIM-1 gene to other newborns.
- Published
- 2023
- Full Text
- View/download PDF
40. Bloodstream infections caused by Escherichia coli carrying mcr-1 gene in hospitalized patients in northern Italy from 2012 to 2018
- Author
-
Mariani, Bianca, Corbella, Marta, Merla, Cristina, Tallarita, Monica, Piralla, Antonio, Girello, Alessia, Castelli, Michele, Bracchi, Chiara, Marone, Piero, and Cambieri, Patrizia
- Published
- 2020
- Full Text
- View/download PDF
41. Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era
- Author
-
Mercuri, Eugenio, Zampino, Giuseppe, Morsella, Alisha, Pane, Marika, Onesimo, Roberta, Angioletti, Carmen, Valentini, Piero, Rendeli, Claudia, Ruggiero, Antonio, Nanni, Lorenzo, Chiaretti, Antonio, Vento, Giovanni, Korn, David, Meneschincheri, Emilio, Sergi, Paolo, Scambia, Giovanni, Ricciardi, Walter, Cambieri, Andrea, and De Belvis, Antonio Giulio
- Published
- 2021
- Full Text
- View/download PDF
42. Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study
- Author
-
Giuseppe Vetrugno, Maurizio Sanguinetti, Rita Murri, Michela Sali, Simona Marchetti, Rosaria Santangelo, Massimo Fantoni, Antonella Cingolani, Giancarlo Scoppettuolo, Michele Di Donato, Vincenzo M. Grassi, Federica Foti, Luca Marchese, Fabio De-Giorgio, Antonio Oliva, Domenico Staiti, Francesco Maria De Simone, Domenico Pascucci, Fidelia Cascini, Roberta Pastorino, Denise Pires Marafon, Andrea Cambieri, Patrizia Laurenti, Stefania Boccia, Walter Ricciardi, Francesco Franceschi, and on behalf of Gemelli-Against-COVID Group
- Subjects
COVID-19 ,lockdown ,swab ,vaccination ,healthcare workers ,Medicine - Abstract
At the onset of the SARS-CoV-2 pandemic, individual and social measures were strengthened through restrictive non-pharmaceutical interventions, labelled with the term “lockdown”. In Italy, there were two lockdowns (9 March 2020–3 May 2020 and 3 November 2020–27 March 2021). As part of preventive measures, healthcare workers and the administrative staff population of Policlinico A. Gemelli underwent nasopharyngeal swab tests from 1 March 2020 to 9 February 2022, a long time interval that includes the two aforementioned lockdowns. The population included 8958 people from 1 March 2020 to 31 December 2020; 8981 people from 1 January 2021 to 31 December 2021; and 8981 people from 1 January 2022 to 9 February 2022. We then analysed pseudo-anonymized data, using a retrospective observational approach to evaluate the impact of the lockdown on the incidence of SARS-CoV-2 infections within the population. Given the 14 day contagious period, the swab positivity rate (SPR) among the staff decreased significantly at the end of the first lockdown, every day prior to 18 May 2020, by 0.093 (p < 0.0001, CI = (−0.138–−0.047)). After the fourteenth day post the end of the first lockdown (18 May 2020), the SPR increased daily at a rate of 0.024 (p < 0.0001, 95% CI = (0.013–0.034)). In addition, the SPR appeared to increase significantly every day prior to 17 November 2020 by 0.024 (p < 0.0001, CI = (0.013–0.034)). After the fourteenth day post the start of the second lockdown (17 November 2020), the SPR decreased daily at a rate of 0.039 (p < 0.0001, 95% CI = (−0.050–−0.027)). These data demonstrate that, in our Institution, the lockdowns helped to both protect healthcare workers and maintain adequate standards of care for COVID and non-COVID patients for the duration of the state of emergency in Italy.
- Published
- 2022
- Full Text
- View/download PDF
43. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy
- Author
-
Farina, C., Vailati, F., Gesu, G., Vismara, C., Arghittu, M., Colombo, R., Torresani, E., Rossi, L., Conaldi, P.G., Gona, F., Cambieri, P., Marone, P., Venditti, C., Fernandez, A. Garcia, Mancini, C., Cusi, M., De Angelis, L. Henrici, Fossati, L., Finarelli, A.C., De Cillia, C., Sangiorgi, G., Pinna, A.D., Stella, F., Viale, P., Colledan, M., Platto, M., Bonizzoli, M., Peris, A., Torelli, R., Vesconi, S., Cibelli, E., De Carlis, L., De Gasperi, A., Ravini, M., Carrinola, R., Coluccio, E., Dondossola, D., Rossi, G., Santambrogio, L., Tosi, D., Feltrin, G., Rago, C., Cillo, U., Da Riva, A., Rea, F., Sparacino, V., Bertani, A., Canzonieri, M., Gridelli, B., Mularoni, A., Spada, M., Carrara, E., D’Armini, A. Maria, Paladini, P., Adorno, D., Valeri, M., Caprio, M., Di Ciaccio, P., Puoti, F., Berloco, P., D’Auria, B., Maldarelli, F., Paglialunga, G., Pugliese, F., Rossi, M., Venuta, F., Amoroso, A., Giacometti, R., Rinaldi, M., Salizzoni, M., Errico, G., Gagliotti, C., Monaco, M., Masiero, L., Gaibani, P., Ambretti, S., Landini, M.P., D’Arezzo, S., Di Caro, A., Parisi, S.G., Palù, G., Vespasiano, F., Morsillo, F., Moro, M.L., Procaccio, F., Ricci, A., Grossi, P.A., Pantosti, A., and Nanni Costa, A.
- Published
- 2019
- Full Text
- View/download PDF
44. Impact of Whole Genome Sequencing to investigate transmission of Serratia marcescens in Neonatal Intensive Care Unit.
- Author
-
Merla, Cristina, Ramus, Marina, Kuka, Angela, Mileto, Irene, Gaiarsa, Stefano, Di Comite, Amelia, Corbella, Marta, Piralla, Antonio, Lanave, Marina Liliana, Muzzi, Alba, Ghirardello, Stefano, Baldanti, Fausto, and Cambieri, Patrizia
- Abstract
Newborns admitted to neonatal intensive care units (NICU) are at increased risk of health care-associated infections. Serratia marcescens represent the third most common pathogen in NICU outbreaks. Here we present an outbreak investigation performed using Whole Genome Sequencing (WGS) analyses and the control measures implemented to limit the spread of S. marcescens in the NICU of an Italian hospital. In February 2023 S. marcescens was isolated from six newborns, when in 2022 this pathogen was isolated only from two samples in the same ward. Measures for infection prevention were adopted. Routinary surveillance screening, performed with rectal swabs collected at admission and weekly thereafter, was implemented to search for S. marcescens presence. Environmental samples were collected. All the isolates, obtained from the conjunctival swab of six newborns, from rectal swab of two newborns who did not develop infections, as well as from the aerators of two faucets, were sequenced. WGS analyses showed no correlation between the isolates from newborns and environmental isolates. The implementation of the measures for infection prevention and control had enabled us to successfully control the outbreak within a short period. WGS analyses proved to be crucial in outbreak investigation to limit the spreading of the pathogens. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. A campaign aimed at increasing seasonal influenza vaccination coverage among post graduate medical residents in an Italian teaching hospital
- Author
-
Andrea Barbara, Marco Mariani, Chiara De Waure, Vincenza Anzelmo, Bruno Piccoli, Andrea Cambieri, Gianfranco Damiani, Walter Ricciardi, and Patrizia Laurenti
- Subjects
preventive healthcare ,influenza vaccines ,medical residents ,teaching hospital ,proactive ,Immunologic diseases. Allergy ,RC581-607 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
We analysed the impact of several strategies aimed at increasing influenza immunisation rates among Medical Residents (MRs) of an Italian teaching Hospital. During the 2015–16 and 2016–17 influenza seasons we carried out several interventions: ambulatory doubling where vaccination was offered, ambulatory opening hour extension, email invitations, informative materials, forum theatre and vaccination campaign conference. In addition, during the 2016–17 the OSV was carried out: MRs who go to specific wards where they perform influenza immunisation counselling and eventually vaccinate the personnel. 99/1041 (9.5%) and 184/1013 (18.2%) MRs received the vaccine in 2015–16 and in 2016–17 respectively (p
- Published
- 2019
- Full Text
- View/download PDF
46. Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center
- Author
-
Antonio Giulio de Belvis, Andrea Barbara, Gabriele Giubbini, Serena Traglia, Carmen Angioletti, Gianluca Ianiro, Luca Masucci, Maurizio Sanguinetti, Patrizia Laurenti, Andrea Cambieri, Antonio Gasbarrini, Walter Ricciardi, and Giovanni Cammarota
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Background: Clostridium Difficile Infections (CDIs) have been increasing both in incidence and in severity, representing a big public health concern. Aim: The aim of this study was to evaluate the impact of a recently implemented Critical Pathway (CP) focused on patients with CDI in an Italian Teaching Hospital. Methods: The CP implementation consisted of intervention aimed to faster diagnosis and appropriateness in admission and discharge point of care; activation of a multidisciplinary team; staff training; information to patients and caregivers.In a pre-post retrospective observational study, volume, process and outcome indicators were analyzed. Findings: A total of 228 patients (128 in 2013 and 100 in 2016) were included. A decrease in the absolute number of access to the Emergency Department (p = 0.02) and an increase in hospitalization in more appropriate ward (ie gastroenterology ward, p
- Published
- 2019
- Full Text
- View/download PDF
47. Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study
- Author
-
Antonio Musarò, Gabriella Dobrowolny, Chiara Cambieri, Emanuela Onesti, Marco Ceccanti, Vittorio Frasca, Annalinda Pisano, Bruna Cerbelli, Elisa Lepore, Gabriele Ruffolo, Pierangelo Cifelli, Cristina Roseti, Carla Giordano, Maria Cristina Gori, Eleonora Palma, and Maurizio Inghilleri
- Subjects
Medicine ,Science - Abstract
Abstract The aim of the study was to verify whether neuromuscular magnetic stimulation (NMMS) improves muscle function in spinal-onset amyotrophic lateral sclerosis (ALS) patients. Twenty-two ALS patients were randomized in two groups to receive, daily for two weeks, NMMS in right or left arm (referred to as real-NMMS, rNMMS), and sham NMMS (sNMMS) in the opposite arm. All the patients underwent a median nerve conduction (compound muscle action potential, CMAP) study and a clinical examination that included a handgrip strength test and an evaluation of upper limb muscle strength by means of the Medical Research Council Muscle Scale (MRC). Muscle biopsy was then performed bilaterally on the flexor carpi radialis muscle to monitor morpho-functional parameters and molecular changes. Patients and physicians who performed examinations were blinded to the side of real intervention. The primary outcome was the change in the muscle strength in upper arms. The secondary outcomes were the change from baseline in the CMAP amplitudes, in the nicotinic ACh currents, in the expression levels of a selected panel of genes involved in muscle growth and atrophy, and in histomorphometric parameters of ALS muscle fibers. The Repeated Measures (RM) ANOVA with a Greenhouse-Geisser correction (sphericity not assumed) showed a significant effect [F(3, 63) = 5.907, p
- Published
- 2019
- Full Text
- View/download PDF
48. The Silent Period for Small Fiber Sensory Neuropathy Assessment in a Mixed Cohort of Transthyretin-Mediated Amyloidosis
- Author
-
Chiara Cambieri, Laura Libonati, Federica Moret, Giorgio Tartaglia, Matteo Garibaldi, Cristina Chimenti, Maurizio Inghilleri, and Marco Ceccanti
- Subjects
transthyretin-mediated amyloidosis ,cutaneous silent period ,mixed nerve silent period ,neurophysiology ,Biology (General) ,QH301-705.5 - Abstract
Background: Transthyretin-mediated amyloidosis (ATTR) is a rare multisystemic disease involving the peripheral nervous system and heart. Autonomic and small fiber involvement is one of the hallmarks of ATTR, and many tools have been proposed to assess this aspect. Aim: The aim of this study was to investigate cutaneous and mixed nerve silent periods (CSP and MnSP) as instruments for small fiber assessment. Methods: A total of 21 ATTR patients, 20 healthy controls, and 18 asymptomatic carriers underwent a sensory conduction study from the right sural and non-dominant ulnar nerves. A motor conduction study from the right deep peroneal and non-dominant ulnar nerves, with their F waves, CSPs, and MnSPs, was performed. Results: The amplitudes of the sural and ulnar sensory nerves and of the peroneal and ulnar motor nerves were reduced in ATTR patients compared to the other groups. F waves from the ulnar and peroneal nerves showed no differences between the three groups. The CSP and MnSP latency, but not amplitude, were increased in both the ulnar and peroneal nerves of ATTR patients. Conclusions: ATTR patients showed axonal involvement of large sensory and motor nerve fibers and demyelinating features of small sensory fibers.
- Published
- 2022
- Full Text
- View/download PDF
49. Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy?
- Author
-
Marta Colaneri, Domenico Di Carlo, Alessandro Amatu, Lea Nadia Marvulli, Marta Corbella, Greta Petazzoni, Patrizia Cambieri, Alba Muzzi, Claudio Bandi, Angela Di Matteo, Paolo Sacchi, Francesco Mojoli, and Raffaele Bruno
- Subjects
ventilator-associated pneumonia ,methicillin-resistant Staphylococcus aureus ,intensive care unit ,negative predictive value ,Therapeutics. Pharmacology ,RM1-950 - Abstract
The guidelines on ventilator-associated pneumonia (VAP) recommend an empiric therapy against methicillin-resistant Staphylococcus aureus (MRSA) according to its prevalence rate. Considering the MRSA and MSSA VAP prevalence over the last 9 years in our tertiary care hospital, we assessed the clinical value of the MRSA nasal-swab screening in either predicting or ruling out MRSA VAP. We extracted the data of 1461 patients with positive bronchoalveolar lavage (BAL). Regarding the MRSA nasal-swab screening, 170 patients were positive for MRSA or MSSA. Overall, MRSA had a high prevalence in our ICU. Despite the COVID-19 pandemic, there was a significant downward trend in MRSA prevalence, while MSSA remained steady over time. Having VAP due to MRSA did not have any impact on LOS and mortality. Finally, the MRSA nasal-swab testing demonstrated a very high negative predictive value for MRSA VAP. Our results suggested the potential value of a patient-centered approach to improve antibiotic stewardship.
- Published
- 2022
- Full Text
- View/download PDF
50. Flu and COVID-19 Vaccination: What Happens to the Flu Shot When the Campaigns Overlap? Experience from a Large Italian Research Hospital
- Author
-
Domenico Pascucci, Mario Cesare Nurchis, Alberto Lontano, Eleonora Marziali, Giuseppe Vetrugno, Andrea Cambieri, Umberto Moscato, Andrea Di Pilla, Gianfranco Damiani, and Patrizia Laurenti
- Subjects
flu vaccination ,COVID-19 ,healthcare workers ,vaccination coverage ,public health ,Medicine - Abstract
Influenza represents a threat to global health and health care workers (HCWs) have an increased risk of contracting the influenza virus in the workplace. The COVID-19 pandemic has brought back the importance of influenza vaccination, as the influenza virus can circulate together with SARS-CoV-2. The aim of this report is to describe the actual flu vaccination coverage among healthcare workers of a research hospital and the trend changes, with respect to the past flu vaccination campaigns, in light of the present pandemic and COVID-19 vaccination. A Pearson’s χ2 test was used to test the correlation of flu vaccination coverage, across all professional categories, between the last two years. A linear regression model was adopted to predict the total vaccination coverage of this year. A statistically significant decrease (p < 0.01) was observed in vaccination coverage among all the professional categories with a 50% reduction in vaccination trends between the last two years. Analyzing the data from the previous six flu vaccination campaigns, the expected value, according to the linear regression model, was estimated to be 38.5% while the observed value was 24%. The decrease in vaccination coverage may be due to the fear of the pandemic situation and especially to the uncertainty related to the consequences of a concurrent administration which may overload the immune system or may be more reactogenic. The COVID-19 pandemic represents an opportunity to promote and support large-scale influenza vaccination among HCWs through structured programs, adequate funding, and tailored communication strategies.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.